We sought to determine the ability of an MVA-TRICOM-based platform to express Twist and stimulate Twist-specific antitumor immune responses in two spontaneously metastasizing murine tumor models where Twist is a “self” tumor-associated antigen. This evidence concerns the gene TWIST1 and neoplasm.